 The primary objective is to compare the efficacy of the treatment using implantable cardioverter defibrillator ICD implantation to that of the treatment using amiodarone in the primary prevention of all-cause mortality in high-risk patients with Chagas cardiomyopathy and non-sustained ventricular tachycardia NSVT. 